RADX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Radiopharm Theranostics Ltd

Watchlist Manager

Watchlist

Price: 0.8901 USD -10.37% Market Closed

Market Cap: $2.1B

	Radiopharm Theranostics Ltd NASDAQ:RADX	AU
G	Gladstone Investment Corp F:1G3	US
A	Alexander's Inc SWB:AXE	US
D	Deutsche Post AG F:DPW	DE
	TherapeuticsMD Inc NASDAQ:TXMD	US
	Organizacion Soriana SAB de CV F:OSOB	MX
M	Microsoft Corp XHAN:MSF	US
T	Trust Securities & Brokerage Ltd KAR:TSBL	PK
S	Simmtech Holdings Co Ltd KOSDAQ:036710	KR
	Vulcan Energy Resources Ltd ASX:VUL	AU

Profitability Summary

Radiopharm Theranostics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

10%

Low 3Y Average Gross Margin

Negative Operating Margin

-1 890%

Negative 3Y Average Operating Margin

-3 719%

Operating Margin is Increasing

-11 707% > -1 890%

Negative Net Margin

-1 992%

Negative 3Y Average Net Margin

-4 551%

Net Margin is Increasing

-11 837% > -1 992%

Negative Free Cash Flow Margin

-1 907%

Negative 3Y Average Free Cash Flow Margin

-2 720%

Free Cash Flow Margin is Increasing

-8 458% > -1 907%

Negative ROE

-159%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-78%

Declining ROIC

-60% > -104%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.